FOXP3 and ductal breast carcinoma in situ: Finally, the high infiltration of FOXP3+ TIL and the presence of PD-L1+ immune cells were associated with tumor recurrence in patients with pure DCIS, suggesting a potential benefit in active surveillance or aggressive treatment in such patient groups.